General MedicationsORALGeneric

ERYTHROMYCIN ESTOLATE

Standard Dose

EQ 125MG BASE

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview ERYTHROMYCIN ESTOLATE is listed in Drugs@FDA under application 062162 (ANDA).

Marketing status: Discontinued Active ingredient ERYTHROMYCIN ESTOLATE Form and strength CAPSULE;ORAL - EQ 125MG BASE Sponsor BARR Submission history Latest submission status date: 2000-07-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERYTHROMYCIN ESTOLATE is listed in Drugs@FDA under application 062162 (ANDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN ESTOLATE Form and strength CAPSULE;ORAL - EQ 125MG BASE Sponsor BARR Submission history Latest submission status date: 2000-07-27 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.